Stock Alert: Sellas Life Sciences Up 50% On Positive Result Of Leukemia Drug

Shares of Sellas Life Sciences Group Inc. (SLS) surged nearly 50% on Wednesday morning after the clinical stage pharma company focused on cancer treatment announced positive trial results of a leukemia drug.